Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Sham-Controlled Trial Investigating Individualized Alpha Neurofeedback Plus Cognitive Training in Paediatric Brain Tumour Survivors

NCT07085494 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT07085494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07085494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Sham-Controlled Trial Investigating Individualized Alpha Neurofeedback Plus Cognitive Training in Paediatric Brain Tumour Survivors
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
August 1, 2025
Completion date
August 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, primary